Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

January 1,
2022

January 2,
2021

Assets

Current assets:

   Cash and cash equivalents

$1,074,623

$   202,720

   Short-term investments

964,582

521,963

   Accounts receivable, net

98,313

95,169

   Inventories

49,307

47,861

   Prepaid expenses and other current assets

51,748

87,103

   Current assets of discontinued operations

--

21,005

Total current assets

2,238,573

975,821

Property and equipment, net

146,516

135,803

Goodwill

376,389

376,389

Other intangible assets, net

118,978

163,483

Other assets, net

77,839

76,675

Non-current assets of discontinued operations

--

265,316

Total assets

$2,958,295

$1,993,487

Liabilities and Stockholders' Equity

Current liabilities:

   Accounts payable

$     47,327

$     54,949

   Current portion of convertible debt, net

450,599

134,480

   Deferred revenue and returns liability

13,849

12,986

   Other current liabilities

157,052

81,650

   Current liabilities of discontinued operations

--

433

Total current liabilities

668,827

284,498

Convertible debt, net

--

428,945

Other non-current liabilities

77,044

79,752

Non-current liabilities of discontinued operations

--

451

Total liabilities

745,871

793,646

Commitments and contingencies

Stockholders' equity:

   Preferred stock – $0.0001 par value; 10,000 shares authorized; no

      shares issued

--

--

   Common stock – $0.0001 par value; 250,000 shares authorized;  

      38,481 and 43,925 shares issued and outstanding at

      January 1, 2022 and January 2, 2021, respectively

4

4

   Additional paid-in capital

--

204,359

   Retained earnings

2,214,839

993,664

   Accumulated other comprehensive income (loss)

(2,419)

1,814

Total stockholders' equity

2,212,424

1,199,841

Total liabilities and stockholders' equity

$2,958,295

$1,993,487